• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  (1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II)
Date Designated:  11/22/2017
Orphan Designation:  Treatment of multiple myeloma
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Phosplatin Therapeutics LLC
1350 6th Avenue
3rd Floor
New York, New York 10019
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-